This inventor holds 1 USPTO granted patent. Top assignee: Luca Science Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Takuya Ishikawa: Innovator in Mitochondrial Expression Vectors
Introduction
Takuya Ishikawa is a prominent inventor based in Sapporo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of expression vectors for mitochondrial applications. His innovative work aims to address critical challenges in protein expression within animal cells.
Latest Patents
Ishikawa holds a patent for a recombinant expression vector and lipid membrane structure that encapsulates the vector. This invention is designed to effectively express target proteins in mitochondria while minimizing unwanted expression in other cell organelles. The recombinant expression vector features a promoter sequence that activates transcription in animal cell nuclei and includes a coding region that specifies a target protein, utilizing one or more TGAs as codons for tryptophan. This technology promises to enhance the efficiency and selectivity of protein expression in mitochondria, offering potential therapeutic benefits for mitochondrial diseases.
Career Highlights
Ishikawa's career is marked by his dedication to advancing biotechnological solutions. His work at Luca Science Inc. has positioned him as a key player in the field, where he continues to innovate and develop new methodologies for protein expression.
Collaborations
Ishikawa collaborates with notable colleagues, including Hideyoshi Harashima and Yuma Yamada. These partnerships enhance the research and development efforts at Luca Science Inc., fostering a collaborative environment that drives innovation.
Conclusion
Takuya Ishikawa's contributions to the field of biotechnology, particularly through his patented recombinant expression vector, highlight his role as a leading inventor. His work not only addresses significant challenges in protein expression but also paves the way for advancements in the treatment of mitochondrial diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile